Comprehensive Mendelian randomization analysis of inflammatory networks in diabetic nephropathy and pituitary adenoma: unveiling complex causal relationships

Fu Yi, Yongyong ChenDiscover 2025 · DOI

Abstract

This comprehensive Mendelian randomization analysis reveals complex, disease-specific inflammatory networks underlying diabetic nephropathy and pituitary adenoma pathogenesis.

Introduction

Inflammation is a critical driver in the pathogenesis of both diabetic nephropathy (DN) and pituitary adenomas (PA). However, establishing a definitive causal link between specific inflammatory biomarkers and these conditions remains challenging due to the inherent limitations of observational studies, such as confounding factors and reverse causality. This study employs Mendelian Randomization (MR) to clarify these causal relationships and investigate whether these two distinct diseases share common inflammatory pathways.

Methods

The researchers utilized a Two-Sample Mendelian Randomization (MR) framework, treating genetic variants (SNPs) as instrumental variables to estimate the causal effects of inflammatory factors on DN and PA.

  • Data Sources: GWAS summary statistics from European populations were used, covering a wide panel of inflammatory factors, diabetic nephropathy (~19,406 cases), and pituitary adenoma (~2,000 cases).
  • Statistical Analysis: The primary analysis used the Inverse Variance Weighted (IVW) method. Robustness was assessed using MR-Egger, weighted median, and weighted mode methods to account for potential pleiotropy. Sensitivity analyses included scatter and funnel plots.

Results

The analysis identified distinct inflammatory signatures for each disease, with no significant causal overlap between them.

Pituitary Adenoma

For pituitary adenoma, two key factors were identified as having significant causal associations:

  • Neurotrophin-3: Genetically predicted higher levels were associated with a reduced risk (OR = 0.754, 95% CI: 0.583–0.975, p = 0.031).
  • Programmed cell death 1 ligand (PD-L1): Genetically predicted higher levels were associated with an increased risk (OR = 1.320, 95% CI: 1.016–1.714, p = 0.037).
Forest plot of causal estimates for inflammatory factors in pituitary adenoma.

Diabetic Nephropathy

The inflammatory profile for diabetic nephropathy was more extensive:

  • Protective Factors: CX3C-motif chemokine 1 (OR = 0.514) and Interleukin-13 (OR = 0.822) showed significant protective effects.
  • Risk Factors: Macrophage colony-stimulating factor (OR = 1.175) and matrix metalloproteinase-10 (OR = 1.142) were identified as causal risk factors.

Cross-Disease Analysis

Bidirectional MR analysis found no evidence of a causal relationship between pituitary adenoma and diabetic nephropathy (OR ≈ 1.0, p > 0.05), suggesting independent pathophysiological mechanisms despite shared inflammatory components.

Discussion

The findings underscore the high degree of specificity in inflammatory networks across different diseases. The identification of protective factors like Interleukin-13 in DN suggests that certain immune responses may serve as endogenous defense mechanisms rather than purely pathogenic drivers. This challenges the narrative of inflammation as a generic detrimental process and highlights the need for precision medicine targeting specific pathways.

Limitations

The study is limited by its focus on European ancestry, which may restrict generalizability to other populations. Additionally, the MR approach assumes linear, lifelong exposure and may not capture the complex temporal dynamics of inflammation across different disease stages. The relatively small sample size for pituitary adenoma may also limit the statistical power to detect more subtle associations.

Conclusion

This study provides genetic evidence for specific inflammatory drivers in diabetic nephropathy and pituitary adenoma. These findings offer validated targets for precision medicine and drug development, emphasizing the importance of disease-specific anti-inflammatory strategies.

Summary updated

Abstract

This comprehensive Mendelian randomization analysis reveals complex, disease-specific inflammatory networks underlying diabetic nephropathy and pituitary adenoma pathogenesis.
BibTeX
@inproceedings{yi2025comprehensive,
  author = {Fu Yi and Yongyong Chen},
  title = {{Comprehensive Mendelian randomization analysis of inflammatory networks in diabetic nephropathy and pituitary adenoma: unveiling complex causal relationships}},
  booktitle = {Discover},
  year = {2025},
  doi = {10.1007/s12672-025-03291-8},
}
Figure